lobbying_activities: 2604595

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2604595	8dda7526-a7a7-4642-8468-2dd9bd94edd9	Q1	BOCKORNY GROUP, INC.	289773	CVS HEALTH INC	2021	first_quarter	PHA	Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021	Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	80000		0	0	2021-04-19T15:34:22.953000-04:00